Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	291-293
Number of pages	0
Journal	Rejuvenation Research
Volume	21
Issue number	4
Early online date	9 Aug 2018
DOIs	https://doi.org/10.1089/rej.2018.2116 https://doi.org/10.1089/rej.2018.2117
Publication status	Published - Aug 2018

Access to Document

@article{1d7a0520b7d5442c8a3a606249606820,

title = "Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence",

author = "Carter, \{Alison R.\} and Edward Meinert and Brindley, \{David A.\}",

year = "2018",

month = aug,

doi = "10.1089/rej.2018.2116",

language = "English",

volume = "21",

pages = "291--293",

journal = "Rejuvenation Research",

issn = "1549-1684",

publisher = "Mary Ann Liebert Inc.",

number = "4",

}

TY - JOUR

T1 - Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence

AU - Carter, Alison R.

AU - Meinert, Edward

AU - Brindley, David A.

PY - 2018/8

Y1 - 2018/8

U2 - 10.1089/rej.2018.2116

DO - 10.1089/rej.2018.2116

M3 - Article

SN - 1549-1684

VL - 21

SP - 291

EP - 293

JO - Rejuvenation Research

JF - Rejuvenation Research

IS - 4

ER -